ITC Will Probe Hemophilia B Med Patent Infringement Claims

By Steven Trader · August 9, 2017, 4:45 PM EDT

The U.S. International Trade Commission has agreed to take up an investigation into whether the importer of a drug used to treat hemophilia B is infringing patents for a similar drug...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Link

Recent Articles By Steven

May 31, 2018
SEC Gets Immigration Atty DQ'd In EB-5 Scam Suit
March 07, 2018
Sen. Feinstein Wants Refugee Resettlement Head To Resign
March 05, 2018
Hospitals Can't Arbitrate Lien Suit, Texas Court Says
February 05, 2018
Surgery Center, Estate Contest Punitives In Meningitis MDL
August 30, 2017
Fed. Regs Can't Be Copyrighted, Nonprofit Tells DC Circ.
August 17, 2017
Fed. Circ. Affirms PTAB Nix Of Root Canal Patent As Obvious
June 14, 2017
New Senior Hit With Shareholder Suit Over $640M Deal
June 13, 2017
Ex-Pot Co. Owner Seeks To Shift SEC Fraud Claims Onto Atty
May 30, 2017
Feds Blast Ex-Tenet Exec's Bid To Nix Fraud Charges
May 03, 2017
MDLive Looks To Toss Users' Data-Sharing Suit